肝硬化肝移植术后脾功能亢进转归的研究进展  

Research progress on the outcome of hypersplenism after liver transplantation for liver cirrhosis

作　　者：黄孟修 汪京 吕少诚[1] 姜涛[1] 潘飞[1] 贺强[1] 郎韧[1] Huang Mengxiu;Wang Jing;Lyu Shaocheng;Jiang Tao;Pan Fei;He Qiang;Lang Ren(Department of Hepatobiliary Surgery,Beijing Chao-Yang Hospital,Capital Medical University,Beijing 100020,China)

机构地区：[1]首都医科大学附属北京朝阳医院肝胆外科,北京100020

出　　处：《中华肝胆外科杂志》2021年第12期957-960,共4页Chinese Journal of Hepatobiliary Surgery

基　　金：首都卫生发展科研专项(2020-1-2036)。

摘　　要：脾功能亢进(脾亢)是常见的脾脏疾病,通常指各种原因导致的脾脏体积增大和(或)血细胞减少的临床综合征。脾亢最常继发于肝硬化门静脉高压症。肝移植术能有效缓解肝硬化患者合并的脾亢,但也存在部分患者经肝移植后脾亢持续存在或缓解后复发。术后顽固性脾亢的其他治疗方式包括脾切除术、部分脾动脉栓塞等。本文就肝硬化合并脾亢行肝移植后脾亢转归的研究进展进行综述。Hypersplenism is the most common splenic disease and usually refers to a clinical syndrome of increased splenic size and/or cytopenia due to various causes.Hypersplenism is most often secondary to cirrhotic hypertension.Liver transplantation can effectively relieve hypersplenism in patients with liver cirrhosis,but there are also some patients with persistent hypersplenism after liver transplantation or recurrence after remission.Other treatment modalities for postoperative intractable hypersplenism include splenectomy and partial splenic artery embolization.This article reviews the research progress of hypersplenism after liver transplantation for liver cirrhosis with hypersplenism.

关 键 词：脾功能亢进 肝硬化 肝移植 顽固性脾亢 

分 类 号：R657.31[医药卫生—外科学] R551.1[医药卫生—临床医学]